findmyKOL
Clinical trialNCT05913752RecruitingPhase 1, PHASE2Interventional

A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects

SponsorClearmind Medicine Inc.Enrollment84Alcohol Use Disorder
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Israel
  • Hadassah Medical Center

    Jerusalem, Israel

    Recruiting
  • Tel-Aviv Sourasky Medical Center (tasmc)

    Tel Aviv, Israel

    Recruiting
United States
  • Connecticut Mental Health Center

    New Haven, Connecticut, United States

    Recruiting
  • Johns Hopkins Bayview Medical Center

    Baltimore, Maryland, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2025
Primary completion
31 Dec 2026
Completion
31 Dec 2026
Last update posted
31 Mar 2026
Registered enrollment
84
Registry id
NCT05913752

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.